A Phase II Trial of Rituximab Combined With Pegfilgrastim in Patients With Indolent B-cell Non-Hodgkin Lymphoma.

Autor: Torka, Pallawi, Patel, Priyank, Tan, Wei, Wilding, Gregory, Bhat, Seema A., Czuczman, Myron S., Lee, Kelvin P., Deeb, George, Neppalli, Vishala, Mavis, Cory, Wallace, Paul, Hernandez-Ilizaliturri, Francisco J.
Zdroj: Clinical Lymphoma, Myeloma & Leukemia; Jan2018, Vol. 18 Issue 1, pe51-e60, 1p
Databáze: Complementary Index